Perspective Therapeutics, Inc.
CATX · Pharmaceutical Preparations · 114.0M shares · +141%/yr ↑ dilution · EDGAR filings ↗
Reference price $2.03 · est. market cap ~$231M — last insider purchase, 2025-11-13 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D46Clinical-stage radiopharmaceutical biotech — heavy burn but well-funded and debt-free.
Strengths
- Cash-rich, debt-free — current ratio 5.2 (60th), D/E 0.0
Risks
- Heavy cash burn — FCF -$95M, ROE -50%
- Pre-revenue/clinical-stage — history of losses & need for additional capital per risk factors
- Pipeline/clinical-outcome dependence — per 10-K
Notable findings
- Cash burnNegative free cash flow (-95.2M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC
- Chronic dilutionShare count +141%/yr over 1y (dilution, book value/share -70%)
- Notable holderHeld by 4 notable fund(s): CITADEL ADVISORS LLC, STATE STREET CORP, GOLDMAN SACHS GROUP INC +1 more (as of 2026-03-31)
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Return on equity
-49.8%
Return on assets
-38.6%
ROIC
-43.0%
Revenue growth (QoQ)
4.6%
Debt / equity
0.0×
Current ratio
5.2×
Free cash flow
-$95M
EBITDA
-$110M
Tangible book value
$207M
Cash & investments
$145M
Cash runway
6q
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2025-11-13 | Hunt Jonathan Robert | Buy | 11K | $2.03 |
| 2025-11-12 | Williamson Robert F III | Buy | 9.5K | $2.10 |
| 2025-03-31 | Woods Lori A | Buy | 23K | $2.13 |
| 2025-03-31 | Williamson Robert F III | Buy | 38K | $2.14 |
| 2025-03-28 | Williamson Robert F III | Buy | 22K | $2.27 |
| 2025-03-28 | Spoor Johan M. | Buy | 22K | $2.24 |
| 2025-03-28 | Graham Juan | Buy | 33K | $2.25 |
| 2025-03-28 | Spoor Johan M. | Buy | 4.7K | $2.21 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-01 | 2026-06-01 | 0001193125-26-249594 ↗ |
| 8-K | 2026-05-27 | 2026-05-27 | 0001193125-26-241940 ↗ |
| 8-K | 2026-05-22 | 2026-05-21 | 0001193125-26-234991 ↗ |
| 8-K | 2026-05-11 | 2026-05-11 | 0001193125-26-216777 ↗ |
| 10-Q | 2026-05-11 | 2026-03-31 | 0001193125-26-216790 ↗ |
| 8-K | 2026-05-04 | 2026-05-04 | 0001193125-26-204161 ↗ |
| 8-K | 2026-04-20 | 2026-04-18 | 0001193125-26-162578 ↗ |
| 8-K | 2026-04-01 | 2026-04-01 | 0001193125-26-137930 ↗ |
| 10-K | 2026-03-16 | 2025-12-31 | 0000728387-26-000004 ↗ |
| 8-K | 2026-03-16 | 2026-03-16 | 0000728387-26-000003 ↗ |
| 8-K | 2026-02-03 | 2026-02-02 | 0001193125-26-035508 ↗ |
| 8-K | 2026-02-02 | 2026-02-02 | 0001193125-26-032706 ↗ |